title: DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas.
abstract: Diffuse large B-cell lymphomas (DLBCL) are the most common type of aggressive lymphomas, with considerable heterogeneity in clinical presentation, molecular characteristics, and outcome. Previous studies have showed significant correlations between DNA methyltransferase (DNMT) overexpression and unfavorable prognosis in human cancers. Therefore, we investigated in this study the biological and prognostic significance of DNMT1, DNMT3a, and DNMT3b protein expression in DLBCL. DNA methyltransferase (DNMT) expression was analyzed by immunohistochemistry in 81 DLBCL cases and correlated with clinicopathological parameters. Kaplan-Meier curves were used to estimate survival rates, and the Cox proportional hazard regression model was used to evaluate the prognostic impact of DNMT expression. Our results showed that overexpression of DNMT1, DNMT3a, and DNMT3b were detected in 48%, 13%, and 45% of investigated cases, respectively. DNA methyltransferase 1 (DNMT1) and DNMT3b overexpression was significantly correlated with advanced clinical stages (P = 0.028 and P = 0.016, respectively). Moreover, concomitant expression of DNMT1 and DNMT3b was significantly correlated with resistance to treatment (P = 0.015). With regard to survival rates, although data was available only for 40 patients, DNMT3b overexpression was significantly correlated with shorter overall survival (P = 0.006) and progression-free survival (P = 0.016). Interestingly, multivariate analysis demonstrated that DNMT3b overexpression was an independent prognostic factor for predicting shortened overall survival (P = 0.004) and progression-free survival (P = 0.024). In conclusion, DNMT3b overexpression was identified as an independent prognostic factor for predicting shortened survival of patients with DLBCL and could be, therefore, useful in identifying patients who would benefit from aggressive therapy.
authors.affiliation: Department of Pathology, Farhat-Hached Hospital, Sousse, Tunisia.
authors.forename: Khaled
authors.initials: K
authors.lastname: Amara
authors.forename: Sonia
authors.initials: S
authors.lastname: Ziadi
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hachana
authors.forename: Nabil
authors.initials: N
authors.lastname: Soltani
authors.forename: Sadok
authors.initials: S
authors.lastname: Korbi
authors.forename: Mounir
authors.initials: M
authors.lastname: Trimeche
mesh_terms: D000368:Aged; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics*; D000090205:DNA Methyltransferase 3A; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D000097584:DNA Methyltransferase 3B
chemical_list: D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; D000097584:DNA Methyltransferase 3B; C000717967:DNMT3A protein, human; C000619380:DNMT1 protein, human
references.citation: Genes Dev. 2007 Dec 1;21(23):3110-22
references.pmid: 18056424
references.citation: J Clin Oncol. 1999 Apr;17(4):1244
references.pmid: 10561185
references.citation: Cancer Res. 2001 May 1;61(9):3581-5
references.pmid: 11325823
references.citation: Nucleic Acids Res. 1997 Nov 15;25(22):4666-73
references.pmid: 9358180
references.citation: Cancer Res. 2001 Apr 15;61(8):3419-24
references.pmid: 11309302
references.citation: Clin Lung Cancer. 2006 Jul;8(1):39-44
references.pmid: 16870044
references.citation: Leukemia. 1998 Mar;12(3):311-6
references.pmid: 9529124
references.citation: Genetics. 1990 Feb;124(2):429-37
references.pmid: 2307364
references.citation: Hum Mol Genet. 2000 Oct;9(16):2395-402
references.pmid: 11005794
references.citation: Int J Cancer. 2007 Dec 15;121(12):2693-702
references.pmid: 17724719
references.citation: Mol Carcinog. 2002 Mar;33(3):163-71
references.pmid: 11870882
references.citation: Nat Rev Genet. 2002 Jun;3(6):415-28
references.pmid: 12042769
references.citation: Hum Pathol. 2003 Jan;34(1):11-7
references.pmid: 12605361
references.citation: Mol Cancer Res. 2004 Jan;2(1):62-72
references.pmid: 14757847
references.citation: Oncol Rep. 2001 Sep-Oct;8(5):1085-9
references.pmid: 11496321
references.citation: Cancer Res. 2003 Oct 1;63(19):6110-5
references.pmid: 14559786
references.citation: Cancer Res. 1999 May 15;59(10):2302-6
references.pmid: 10344733
references.citation: Science. 1980 Nov 7;210(4470):604-10
references.pmid: 6254144
references.citation: Oncogene. 2001 May 28;20(24):3139-55
references.pmid: 11420731
references.citation: Nature. 2000 Feb 3;403(6769):503-11
references.pmid: 10676951
references.citation: Int J Mol Med. 2007 Jul;20(1):65-73
references.pmid: 17549390
references.citation: Mod Pathol. 2008 Mar;21(3):282-96
references.pmid: 18165800
references.citation: Curr Opin Oncol. 2004 Sep;16(5):436-41
references.pmid: 15314511
references.citation: Zhonghua Nei Ke Za Zhi. 2003 Oct;42(10):688-91
references.pmid: 14633461
references.citation: World J Gastroenterol. 2009 Apr 28;15(16):2020-6
references.pmid: 19399937
references.citation: Int J Cancer. 2003 Jul 1;105(4):527-32
references.pmid: 12712445
references.citation: Br J Cancer. 2008 May 20;98(10):1716-22
references.pmid: 18414412
references.citation: Ann Oncol. 2008 Oct;19(10):1774-86
references.pmid: 18539616
references.citation: J Clin Oncol. 2006 Feb 20;24(6):995-1007
references.pmid: 16418498
references.citation: Dig Dis Sci. 2008 Aug;53(8):2083-9
references.pmid: 18253830
references.citation: Lung Cancer. 2007 Feb;55(2):205-13
references.pmid: 17140695
references.citation: Cancer. 2006 Sep 1;107(5):1042-9
references.pmid: 16888795
references.citation: Cell. 1999 Oct 29;99(3):247-57
references.pmid: 10555141
references.citation: Nat Genet. 2003 Jan;33(1):61-5
references.pmid: 12496760
references.citation: Cancer Lett. 2006 Feb 28;233(2):271-8
references.pmid: 15885882
references.citation: Blood. 2001 Mar 1;97(5):1172-9
references.pmid: 11222358
references.citation: Clin Cancer Res. 2003 Oct 1;9(12):4415-22
references.pmid: 14555514
references.citation: Cancer Res. 2006 Sep 1;66(17):8361-6
references.pmid: 16951144
references.citation: Cancer Lett. 2005 Aug 8;226(1):77-84
references.pmid: 16004934
references.citation: Nucleic Acids Res. 1999 Jun 1;27(11):2291-8
references.pmid: 10325416
references.citation: Hum Mol Genet. 2003 Sep 1;12(17):2209-19
references.pmid: 12915469
references.citation: Science. 1997 Sep 26;277(5334):1996-2000
references.pmid: 9302295
references.citation: Blood. 2004 Jan 1;103(1):275-82
references.pmid: 14504078
references.citation: N Engl J Med. 1993 Sep 30;329(14):987-94
references.pmid: 8141877